找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Leukemia Stem Cells in Hematologic Malignancies; Haojian Zhang,Shaoguang Li Book 2019 The Editor(s) (if applicable) and The Author(s), und

[复制链接]
楼主: gloomy
发表于 2025-3-26 22:20:40 | 显示全部楼层
发表于 2025-3-27 02:58:40 | 显示全部楼层
发表于 2025-3-27 06:05:48 | 显示全部楼层
发表于 2025-3-27 09:59:03 | 显示全部楼层
发表于 2025-3-27 15:24:34 | 显示全部楼层
发表于 2025-3-27 19:52:11 | 显示全部楼层
Book 2019ic strategies need to be developed by focusing on the complete eradication of LSCs. Given its scope, the book offers a valuable asset for graduate students and scientists in the fields of cell biology and cancer research etc..
发表于 2025-3-27 22:59:22 | 显示全部楼层
Cellular and Molecular State of Myeloid Leukemia Stem Cells,SCs, and the dynamic cross talk between LSCs and bone marrow microenvironment. These specific features of LSCs highlight the dynamic cellular state of LSCs, and further exploring on it might provide potential therapeutic targets that are important for eliminating LSCs.
发表于 2025-3-28 03:33:33 | 显示全部楼层
发表于 2025-3-28 08:01:21 | 显示全部楼层
发表于 2025-3-28 13:52:17 | 显示全部楼层
Cellular Immunotherapy in the Treatment of Hematopoietic Malignancies,ptor (CAR) T cell therapy, and CAR-T cell clinical trials in leukemia, lymphoma, and multiple myeloma. Clinical trials have shown encouraging results, but future studies may need to incorporate novel CAR constructs or targets with enhanced safety and efficacy to ensure long-term benefits.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-28 07:53
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表